Abstract
Following in vitro lipofection transfection of the rat glioma cell line A15A5 with the plasmid transgene CMV/HyTK, which confirms hygromycin resistance and ganciclovir sensitivity, a series of experiments was planned in which the “bystander” phenomenon would be evaluated using the rodent implantation glioma model. However examination of the brain of rodents in which the A15A5-HyTK cells were implanted showed no evidence of glioma growth. Furthermore, rodents having intracerebral implantation of (i) wild A15A5 and A15A5HyTK cells in a 50/50 mix, (ii) wild A15A5 and A15A5HyTK cells in a 90/10 mixture and (iii) wild C6 and A15A5HyTK cells in a 50/50 mix all failed to grow macroscopic tumours by 15–17 days irrespective of whether the animals had been administered ganciclovir (GCV) in the week before sacrifice. Neuropathological and immunocytochemical analysis of the implantation sites showed no difference between the GCV and saline treated groups of animals for any implantation cell mix. These observations confirm previous results that suggest transduction of malignant rodent glioma cell lines with a variety of selection, oncogenic and marker genes significantly impairs their in vivo tumorigenic potential compared to the wild type cell lines. This study also demonstrates that even without GCV treatment the transduced cells inhibit, by an unknown mechanism(s), the tumorigenicity of other non transfected malignant cells. The implications of this study for gene therapy of human malignant glioma are discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Barba D, Hardin J, et al (1994) Development of anti-tumor immunity following thymidine kinase-mediated killing of experimental brain tumors. Proc Natl Acad Sci USA 91: 4348–4352
Beaumont A, Clarke M, Whittle IR (1996) The effects of malignant glioma on the EEG and seizure thresholds; an experimental study. Acta Neurochir (Wien) 138: 370–381
Culver KW, Ram Z, Walbridge S et al (1992) In vivo gene transfer with retroviral vector producer cells for treatment of experimental brain tumors. Science 256: 1550–1552
Freeman SM, Abboud C, Whartenby K et al (1993) The “bystander effect”: Tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res 53: 5274–5283
Kramm CM, Sena-Esteves M et al (1995) Gene therapy for brain tumours. Brain Pathol 5: 346–381
Lichtor T, Glick RP et al (1995) Prolonged survival of mice with glioma injected intracerebrally with double cytokine-secreting cells. J Neurosurg 83: 1038–1044
Lupton SD, Brunton LL, Kalberg VA et al (1991) Dominant positive and negative selection using a hygromycin phosphotransferase-thymidine kinase fusion gene. Mol Cell Biol 11: 3374–48
Malcolm G, Kelly PA, Whittle IR et al (1995) Experimental implantation glioma using the A15A5 cell line. J Neurol Neurosurg Psychiatry 58: 390–191
MacArthur D, Malcolm G, Ironside JW, Whittle IR (1995) Can experimental models of implantation glioma be improved? Br J Neurosurg 9: 251–252
Moolten FL, Wells JM (1990) Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors. J Natl Cancer Inst 82: 297–300
Samejima Y, Meruelo D (1995) “Bystander killing” induces apoptosis and is inhibited by forskolin. Gene Ther 2: 50–58
Schwartz MS, Morris J, Sarid J (1991) Overexpression of oncogene products can cause tumor progression without parenchymal infiltration in the rat brain. Cancer Res 50: 3595–3601
Takamiya Y, Short MP, Ezzadine ZD et al (1992) Gene therapy of malignant brain tumors: a rat glioma line bearing the herpes simplex virus type a-thymidine kinase gene and wild type retrovirus kills other tumor cells. J Neurosci Res 33: 493–503
Tapscott SJ, Miller AD et al (1994) Gene therapy of rat 9L gliosarcoma tumors by transduction with selectable genes does not require drug selection. Proc Natl Acad Sci USA 91: 8185–8189
Vrionis FD, Wu JK, Qi P et al (1996) Tumor cells expressing the herpes simplex virus-thymidine kinase gene in the treatment of Walker 256 meningeal neoplasia in rats. J Neurosurg 84: 250–257
Wu JK, Cano WG, Sven AG et al (1994) Bystander tumoricidal effect in the treatment of experimental brain tumours. Neurosurgery 35: 1094–1103
Whittle IR, Macarthur DC, Malcolm GP et al (1996) Can experimental implantation models of rodent glioma be improved? A study of pure and mixed glioma cell line tumours. Acta Neurochir (Wien) submitted
Author information
Authors and Affiliations
Editor information
Rights and permissions
Copyright information
© 1997 Springer-Verlag Wien
About this paper
Cite this paper
Whittle, I.R., Kimber, W.L., Li, M., Bell, H.S., Ironside, J.W. (1997). Glioma Cells Transduced with Selection Transgenes May Not Form Gliomas in vivo and Can Also Inhibit Glioma Formation by Admixed Wild Glioma Cell Lines. In: Ostertag, C.B., Thomas, D.G.T., Bosch, A., Linderoth, B., Broggi, G. (eds) Advances in Stereotactic and Functional Neurosurgery 12. Acta Neurochirurgica Supplements, vol 68. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6513-3_26
Download citation
DOI: https://doi.org/10.1007/978-3-7091-6513-3_26
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-7341-1
Online ISBN: 978-3-7091-6513-3
eBook Packages: Springer Book Archive